These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27821613)

  • 41. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up.
    dos Santos Pde N; Modesto WO; Dal'Ava N; Bahamondes MV; Pavin EJ; Fernandes A
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):432-8. PubMed ID: 25047227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Herpes simplex virus type 2 incidence and associated risk factors among female sex workers in a high HIV-prevalence area of China.
    Wang H; Reilly KH; Smith MK; Brown K; Jin X; Xu J; Ding G; Zang C; Wang J; Wang N
    Int J STD AIDS; 2013 Jun; 24(6):441-6. PubMed ID: 23970745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and Acceptability of Community-Based Distribution of Injectable Contraceptives: A Pilot Project in Mozambique.
    Jacinto A; Mobaracaly MR; Ustáb MB; Bique C; Blazer C; Weidert K; Prata N
    Glob Health Sci Pract; 2016 Sep; 4(3):410-21. PubMed ID: 27651076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Injectable hormone contraception and bone density: results from a prospective study.
    Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM
    Epidemiology; 2002 Sep; 13(5):581-7. PubMed ID: 12192229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of depot medroxyprogesterone acetate and fracture risk.
    Meier C; Brauchli YB; Jick SS; Kraenzlin ME; Meier CR
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4909-16. PubMed ID: 20685865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector.
    Liu J; Schatzkin E; Omoluabi E; Fajemisin M; Onuoha C; Erinfolami T; Ayodeji K; Ogunmola S; Shen J; Diamond-Smith N; Sieverding M
    Contraception; 2018 Nov; 98(5):438-448. PubMed ID: 30071196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
    Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
    Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.
    Cover J; Ba M; Drake JK; NDiaye MD
    Contraception; 2019 Feb; 99(2):137-141. PubMed ID: 30439358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential Elevation of Inflammation and CD4
    Omollo K; Lajoie J; Oyugi J; Wessels JM; Mwaengo D; Kimani J; Kaushic C; Fowke KR
    Front Immunol; 2020; 11():598307. PubMed ID: 33717049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use.
    Cursino K; Sider M; Pavin EJ; dos Santos Pde N; Bahamondes L; Zantut-Wittmann DE; Fernandes A
    Eur J Contracept Reprod Health Care; 2016; 21(1):22-9. PubMed ID: 26140543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone mineral density testing, and bisphosphonate and oestrogen prescribing associated with depot medroxyprogesterone acetate utilization-The impact of the boxed warning.
    Eworuke E; Popat V; Moeny DG
    J Clin Pharm Ther; 2017 Aug; 42(4):483-494. PubMed ID: 28543135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States.
    Upadhyay UD; Zlidar VM; Foster DG
    Contraception; 2016 Oct; 94(4):303-13. PubMed ID: 27326938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What impact could DMPA use have had in South Africa and how might its continued use affect the future of the HIV epidemic?
    Beacroft L; Smith JA; Hallett TB
    J Int AIDS Soc; 2019 Nov; 22(11):e25414. PubMed ID: 31729195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV; Castro S; Marchi NM; Marcovici M; Andrade LA; Fernandes A; Bahamondes L
    Contraception; 2014 Aug; 90(2):117-22. PubMed ID: 24613369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased 1-year continuation of DMPA among women randomized to self-administration: results from a randomized controlled trial at Planned Parenthood.
    Kohn JE; Simons HR; Della Badia L; Draper E; Morfesis J; Talmont E; Beasley A; McDonald M; Westhoff CL
    Contraception; 2018 Mar; 97(3):198-204. PubMed ID: 29246818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland].
    Lech MM
    Wiad Lek; 2003; 56(7-8):362-8. PubMed ID: 14969166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.
    Morrison C; Fichorova RN; Mauck C; Chen PL; Kwok C; Chipato T; Salata R; Doncel GF
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):109-17. PubMed ID: 24413042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.